(1α,4α,6β)-()-1,3,3-trimethyl-2-oxabicyclo[2.2.2]octan-6-ol (66965-45-5)
Identification |
Properties |
Safety Data |
|
|
Other Product
- (1α,2β,4β,6α)-()-2,2,7-trimethyl-3-oxatricyclo[4.1.1.02,4]octane
- (3'α,4'α,5'β,6'aα)-5'-(benzoyloxy)hexahydrospiro[1,3-dioxolane-2,2'(1'H)-pentalene]-4'-methanol
- (1α,3α,4α,5β)-1,3,4,5-tetrahydroxycyclohexane-1-carboxylic acid, compound with 4-hydroxy-α-[1-[(1-methyl-2-phenoxyethyl)amino]ethyl]benzenemethanol (1:1)
- [1R-(1α,4α,6α)-4,7,7-trimethylbicyclo[4.1.0]heptan-3-one
- [3R-(3α,3aβ,7β,8aα)]-2,3,4,7,8,8a-hexahydro-3,8,8-trimethyl-1H-3a,7-methanoazulene-6-methanol
- l-Proline, 5-oxo-, compd. with [4S-(4α,4aα,5α,5aα,6β,12aα)]-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide (1:1)
- [2S-(2α,5α,6β)]-3,3-dimethyl-7-oxo-6-[(phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, compound with α-phenylbenzylamine
- α-cyano-4-fluoro-3-phenoxybenzyl [1α(S*),3β]-()-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate
- (1α,2β,4β,5α,7β)-()-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl (hydroxymethyl)phenylacetate hydrochloride
- [7(S)-(1α,2β,4β,5α,7β)]-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl (hydroxymethyl)phenylacetate
- 3-Cyclohexene-1-methanol, α,α,4-trimethyl-, hydroformylation products
- (4α,8α,9β,13α,14β,17Z)-16β-acetoxy-3α,11α-dihydroxy-29-nordammara-17(20),24-dien-21-oic acid, compound with 2,2'-iminodiethanol (1:1)
- 5α-bromo-6β-chloro-3β,17α-dihydroxypregnane-21-carboxylic acid γ-lactone
- α,α,6-trimethyl-7-oxabicyclo[4.1.0]heptane-3-methyl acetate
- (2α,3aβ,5α,6β,6aβ)]-hexahydro-4-methyl-2,5-methano-2H-furo[3,2-b]pyrrol-6-ol hydrobromide
- Acetic acid, [(6-hydroxy-4-methyl-2-oxo-2H-1-benzopyran-7-yl)oxy]-, compd. with [4S-(4α,4aα,5aα,6β,12aα)]-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamid
- 5-oxo-L-proline, compound with [7(S)-(1α,2β,4β,5α,7β)]-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl α-(hydroxymethyl)benzeneacetate (1:1)
- l-Proline, 5-oxo-, compd. with [4S-(4α,4aα,5aα,6β,12aα)]-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide (1:1)
- Sulfamic acid, cyclohexyl-, compd. with [4S-(4α,4aα,5aα,6β,12aα)]-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide (1:1)
- 2,4-Hexadienoic acid, (E,E)-, compd. with [4S-(4α,4aα,5aα,6β,12aα)]-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide (1:1)